We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLRO icon
4151
ClearOne Inc
CLRO
$10.9M
$309K ﹤0.01%
7,538
CIX icon
4152
Comp X International
CIX
$349M
$308K ﹤0.01%
14,844
+3,445
+30% +$75.7K
RTLR
4153
DELISTED
Rattler Midstream LP Common Units
RTLR
$308K ﹤0.01%
28,222
DLHC icon
4154
DLH Holdings
DLHC
$70.7M
$307K ﹤0.01%
26,286
+3,103
+13% +$34.3K
BBJP icon
4155
JPMorgan BetaBuilders Japan ETF
BBJP
$17.5B
0
GTIM icon
4156
Good Times Restaurants
GTIM
$14.6M
$306K ﹤0.01%
74,904
+16,867
+29% +$73.2K
MREO
4157
Mereo BioPharma
MREO
$54.7M
$306K ﹤0.01%
96,630
+63,643
+193% +$214K
PCSA icon
4158
Processa Pharmaceuticals
PCSA
$5.95M
$306K ﹤0.01%
75
+19
+34% +$73.4K
TUEM
4159
DELISTED
Tuesday Morning Corp
TUEM
$306K ﹤0.01%
+2,267
New +$303K
APWC icon
4160
Asia Pacific Wire & Cable
APWC
$60.6M
$305K ﹤0.01%
76,311
-16,654
-18% -$61.5K
ORKA
4161
Oruka Therapeutics
ORKA
$5.82B
$305K ﹤0.01%
7,305
+709
+11% +$29.6K
BCDA icon
4162
BioCardia
BCDA
$12.3M
$304K ﹤0.01%
5,122
+977
+24% +$59.3K
TLGT
4163
DELISTED
Teligent, Inc
TLGT
$304K ﹤0.01%
569,927
+327,865
+135% +$187K
CENN icon
4164
Cenntro
CENN
$7.89M
$303K ﹤0.01%
52
+24
+86% +$136K
NNVC icon
4165
NanoViricides
NNVC
$38.8M
$302K ﹤0.01%
65,271
BGMS
4166
Bio Green Med Solution Inc
BGMS
$4.91M
$301K ﹤0.01%
14
+8
+133% +$198K
AXAS
4167
DELISTED
Abraxas Petroleum Corp
AXAS
$299K ﹤0.01%
92,582
-4,797
-5% -$12.7K
GHSI
4168
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$298K ﹤0.01%
3,397
+548
+19% +$47.6K
RENO
4169
DELISTED
Renovare Environmental, Inc. Common Stock
RENO
$298K ﹤0.01%
205,937
+114,014
+124% +$162K
BMRA icon
4170
Biomerica
BMRA
$4.6M
$297K ﹤0.01%
9,259
+1,224
+15% +$41.5K
ACIU icon
4171
AC Immune
ACIU
$223M
$294K ﹤0.01%
37,118
+1,650
+5% +$11.4K
DCOY
4172
Decoy Therapeutics
DCOY
$2.19M
$293K ﹤0.01%
8
+5
+167% +$222K
SALM
4173
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$293K ﹤0.01%
115,038
+27,096
+31% +$61.3K
BOWX
4174
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$293K ﹤0.01%
+25,556
New +$310K
BKSC
4175
DELISTED
Bank of South Carolina
BKSC
$293K ﹤0.01%
14,335
+962
+7% +$19.8K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.